在MAFLD中对SLC载体的技术支持的洞察力:重新定义多击病原和治疗景观
Joseph Tawai1,2, Jing Xiong3,4
1Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
Acta pharmacologica Sinica
|March 4, 2026
概括
溶质载体 (SLC) 载体是代谢功能障碍相关脂肪肝疾病 (MAFLD) 的关键. 像人工智能和冷EM这样的新技术正在揭示它们的作用,并为MAFLD提供新的治疗策略.
科学领域:
- 生物化学 生物化学
- 基因组学就是基因组学.
- 人工智能的人工智能
- 结构生物学 结构生物学
背景情况:
- 溶质载体 (SLC) 载体越来越多地被认为在代谢功能障碍相关的脂肪肝疾病 (MAFLD) 复杂病原发生过程中的关键作用.
- 对于MAFLD的经典"双击"假设正在被扩展,以纳入涉及SLC载体的多击性质.
- 技术的进步对于理解这些复杂的生物系统至关重要.
研究的目的:
- 审查研究SLC载体的最新技术进展.
- 总结SLC载体在MAFLD病原体中的机械作用.
- 讨论针对SLC载体治疗MAFLD治疗的治疗影响.
主要方法:
- 基因功能的基于CRISPR的查.
- 电子显微镜 (cryo-EM) 用于高分辨率的结构确定.
- 人工智能 (AI) 平台 (例如AlphaFold,RosettaVS) 用于蛋白质结构预测和分析.
- 超大虚拟选用于发现小分子抑制剂.
主要成果:
- 在MAFLD中涉及的特定SLC载体 (例如SLC13A5,SLC25A47) 的识别.
- 确定药物设计目标的高分辨率结构 (例如SLC5A2,SLC16A10).
- 通过虚拟查加速发现SLC载体的小分子抑制剂.
结论:
- SLC载体是MAFLD病原体的核心,影响脂质/葡萄糖代谢,线粒体功能和肠肝轴.
- 技术创新正在推动对MAFLD的精准医学方法.
- 针对SLC载体提供了有前途的治疗途径,包括重新定位的药物和新型药物.
相关概念视频
Membrane Transporters
18.6K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
18.6K
Membrane Asymmetry Regulating Transporters
7.7K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
7.7K
Active Transport
2.4K
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
2.4K
Glucose Transporters
27.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
6.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.7K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
81
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
81


